<DOC>
	<DOC>NCT01214317</DOC>
	<brief_summary>The purpose of this study is to compare the effect of combinative induction therapy with mitoxantrone and plasmapheresis versus induction therapy with mitoxantrone alone in cases of aggressive multiple sclerosis</brief_summary>
	<brief_title>Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<criteria>Aggressive multiple sclerosis in attack phase EDSS: 15 No contraindication for mitoxantrone prescription No past history of mitoxantrone injection No history of corticosteroid and immunosuppressive therapy in last 3 months Patient's incompliance Severe drug induced side effects</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>multiple sclerosis</keyword>
	<keyword>mitoxantrone</keyword>
	<keyword>plasmapheresis</keyword>
	<keyword>induction therapy</keyword>
</DOC>